<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="brief-report" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Journal of microbiology, epidemiology and immunobiology</journal-id><journal-title-group><journal-title xml:lang="en">Journal of microbiology, epidemiology and immunobiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Журнал микробиологии, эпидемиологии и иммунобиологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0372-9311</issn><issn publication-format="electronic">2686-7613</issn><publisher><publisher-name xml:lang="en">Central Research Institute for Epidemiology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">13514</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Short Communication</subject></subj-group></article-categories><title-group><article-title xml:lang="en">PROGNOSTIC VALUE OF LIPOPOLYSACCHARIDE AND LIPOPOLYSACCHARIDE-BINDING PROTEIN SERUM LEVELS IN CANCER PATIENTS WITH SEPSIS</article-title><trans-title-group xml:lang="ru"><trans-title>ПРОГНОСТИЧЕСКОЕ ЗНАЧЕНИЕ СЫВОРОТОЧНОГО УРОВНЯ ЛИПОПОЛИСАХАРИДА И ЛИПОПОЛИСАХАРИД-СВЯЗЫВАЮЩЕГО БЕЛКА У ОНКОЛОГИЧЕСКИХ БОЛЬНЫХ С СЕПСИСОМ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Anisimova</surname><given-names>N. Yu</given-names></name><name xml:lang="ru"><surname>Анисимова</surname><given-names>Н. Ю</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gromova</surname><given-names>E. G</given-names></name><name xml:lang="ru"><surname>Громова</surname><given-names>Е. Г</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kuznetsova</surname><given-names>L. S</given-names></name><name xml:lang="ru"><surname>Кузнецова</surname><given-names>Л. С</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kiselevsky</surname><given-names>M. V</given-names></name><name xml:lang="ru"><surname>Киселевский</surname><given-names>М. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Blokhin Russian Oncological Scientific Center, Moscow, Russia</institution></aff><aff><institution xml:lang="ru">Российский онкологический научный центр им. Н.Н.Блохина, Москва</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2011-04-15" publication-format="electronic"><day>15</day><month>04</month><year>2011</year></pub-date><volume>88</volume><issue>2</issue><issue-title xml:lang="en">NO2 (2011)</issue-title><issue-title xml:lang="ru">№2 (2011)</issue-title><fpage>82</fpage><lpage>84</lpage><history><date date-type="received" iso-8601-date="2023-06-09"><day>09</day><month>06</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2011, Anisimova N.Y., Gromova E.G., Kuznetsova L.S., Kiselevsky M.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2011, Анисимова Н.Ю., Громова Е.Г., Кузнецова Л.С., Киселевский М.В.</copyright-statement><copyright-year>2011</copyright-year><copyright-holder xml:lang="en">Anisimova N.Y., Gromova E.G., Kuznetsova L.S., Kiselevsky M.V.</copyright-holder><copyright-holder xml:lang="ru">Анисимова Н.Ю., Громова Е.Г., Кузнецова Л.С., Киселевский М.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://microbiol.crie.ru/jour/article/view/13514">https://microbiol.crie.ru/jour/article/view/13514</self-uri><abstract xml:lang="en"><p>Aim. Analysis of LPS and LPS-binding protein (LBP) serum levels and prognostic value evaluation in cancer patients with sepsis. Materials and methods. Blood samples of 17 healthy donors and 46 cancer patients with sepsis were analyzed by using «Hycult biotechnology» kits (the Netherlands). Results. Serum LPS level in cancer patients with sepsis was increased significantly. A substantial decrease of LBP level was detected in blood samples of deceased patients. Conclusion. Dynamic increase of LPS serum level and decrease of LPS-binding protein serum level in cancer patients should be considered as an unfavo- rable factor for sepsis.</p></abstract><trans-abstract xml:lang="ru"><p>Цель. Определение уровня сывороточной концентрации ЛПС и ЛПС-связывающего белка (ЛСБ), а также оценка его прогностической значимости у онкологических больных с сепсисом. Материалы и методы. Были проанализированы образцы крови 17 здоровых доноров и 46 онкологических больных с диагнозом сепсис с использованием наборов реагентов фирмы «Hycult biotechnology» (Netherlands). Результаты. У онкологических больных с сепсисом содержание сывороточного ЛПС достоверно повышено. В крови умерших больных выявляли значительное снижение содержания ЛСБ. Заключение. Динамическое нарастание концентрации ЛПС и снижение уровня ЛПС-связывающего белка в крови онкологических больных следует рассматривать как прогностически неблагоприятные признаки при сепсисе.</p></trans-abstract><kwd-group xml:lang="en"><kwd>lipopolysaccharide</kwd><kwd>lipopolysaccharide-binding protein</kwd><kwd>sepsis</kwd><kwd>cancer patients</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>липополисахарид</kwd><kwd>липополисахарид-связывающий белок</kwd><kwd>сепсис</kwd><kwd>онкологические больные</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Angus D.C., Linde-Zwirble W.T., Lidicker J. et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit.Care Med. 2001, 29: 1303–1310.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Balzan S., Quadros C. A., Cleva R. B. et al. Bacterial translocation: Overview of mechanisms and clinical impact. J. Gastroenterol. Hepatol. 2007, 22(4): 464–471.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Claudi S.M. Nijhuis O., Vellenga E. et al. Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients. Int. Care Med. 2003, 29(12) : 2157–2161.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Deitch E.A., Bridges R.M. Effect of stress and trauma on bacterial translocation from the gut. J. Surg Res. 1987, 42(5): 536–542.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Myc A., Buck J., Gonin J. et al. The level of lipopolysaccharide-binding protein is significantly increased in plasma in patients with the systemic inflammatory response syndrome. Clin. Diagn. Lab. Immunol. 1997, 4: 113–116.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Takeshita S., Tsujimoto H., Kawase H. et al. Increased levels of lipopolysaccharide binding protein in plasma in children with kawasaki disease. Ibid. 2002, 9(1): 205–206.</mixed-citation></ref></ref-list></back></article>
